
The National Institutes of Health gave a five-year, $4.8 million grant to the Boston University School of Medicine (BUSM) and College of Engineering (COE) to create a low-cost detection platform for multiple viruses.
A news release from BU points to current obstacles in virus detection – high costs, long processing times and training requirements.
BU’s diagnostic platform, which initially brought in seed funding from the BU Photonics Center, is expected to detect Ebola, Lassa Fever and Marburg.
The research team, made up of scentists from both the BUSM and the COE, plan to find infectious agents using engineering and physics developments with nanotechnology. One potential solution consists of researchers building chips with microfluidics incorporated to sense and capture viruses. A reader then analyzes the chip data to identify the presence of viruses.
The testing of the platform will be conducted at the University of Texas Medical Branch.
Read more about BU’s virus detection platform.
Editor's note: An earlier version misstated what schools the research team stemmed from; The team is made up of researchers from both the BUSM and the COE.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Print
Email
Print Edition Stories



